A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus
Wendy Cozen(University of Southern California), Maria Timofeeva(Centre International de Recherche sur le Cancer), D. Li(Cedars-Sinai Medical Center), Arjan Diepstra(University Medical Center Groningen), Dennis J. Hazelett(University of Southern California), Manon Delahaye-Sourdeix(Centre International de Recherche sur le Cancer), Christopher K. Edlund(University of Southern California), Lude Franke(University Medical Center Groningen), Klaus Rostgaard(Institut de Recherche Vaccinale), D. J. Van Den Berg(University of Southern California), Victoria K. Cortessis(University of Southern California), Karin E. Smedby(Karolinska Institutet), Sally L. Glaser(Cancer Prevention Institute of California), Harm-Jan Westra(University Medical Center Groningen), Leslie L. Robison(St. Jude Children's Research Hospital), Thomas M. Mack(University of Southern California), Hervé Ghesquières(Université Claude Bernard Lyon 1), Amie E. Hwang(University of Southern California), Alexandra Nieters(University of Freiburg), Silvia de Sanjosé(Institut d'Investigació Biomédica de Bellvitge), J. Timothy Lightfoot(University of York), Nikolaus Becker(German Cancer Research Center), M. Maynadie(Centre Hospitalier Universitaire Dijon Bourgogne), Lenka Foretová(Masaryk Memorial Cancer Institute), Eve Roman(University of York), Yolanda Benavente(Institut d'Investigació Biomédica de Bellvitge), Kristin A. Rand(University of Southern California), Bharat N. Nathwani(City Of Hope National Medical Center), Bengt Glimelius(Uppsala University), Anthony Staines(Dublin City University), Paolo Boffetta(Icahn School of Medicine at Mount Sinai), Brian K. Link(University of Iowa), Lambertus A. Kiemeney(Radboud University Nijmegen), Stephen M. Ansell(Mayo Clinic), Ravi Bhatia(City Of Hope National Medical Center), Louise C. Strong(The University of Texas MD Anderson Cancer Center), Pilar Galán(Centre de Recherche Épidémiologie et Statistique), Lars J. Vatten(Norwegian University of Science and Technology), Thomas M. Habermann(Mayo Clinic), Eric J. Duell(Institut d'Investigació Biomédica de Bellvitge), Annette Lake(University of Glasgow), Rianne Veenstra(University Medical Center Groningen), Lydia Visser(University Medical Center Groningen), Yuxuan Liu(University Medical Center Groningen), Kevin Y. Urayama(Tokyo Medical and Dental University), Dorothy Montgomery(University of Glasgow), Valérie Gaborieau(Centre International de Recherche sur le Cancer), Lawrence M. Weiss, Graham Byrnes(Centre International de Recherche sur le Cancer), Mark Lathrop(Génome Québec), Pierluigi Cocco(University of Cagliari), Timothy Best(University of Chicago), Andrew D. Skol(University of Chicago), Hans‐Olov Adami(Harvard University Press), Mads Melbye(Statens Serum Institut), James R. Cerhan(Mayo Clinic), A. Gallagher(University of Glasgow), G. Malcolm Taylor, Susan L. Slager(WinnMed), Paul Brennan(Centre International de Recherche sur le Cancer), Gerhard A. Coetzee(University of Southern California), David V. Conti(University of Southern California), Kenan Onel(University of Chicago), Ruth F. Jarrett(MRC University of Glasgow Centre for Virus Research), Henrik Hjalgrim(Institut de Recherche Vaccinale), Anke van den Berg(University Medical Center Groningen), James McKay(Centre International de Recherche sur le Cancer)
Cited by 89Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis